Neogen reports Q1 results exceeding revenue expectations, despite sales decline, and raises full-year guidance

Neogen's Q1 CY2026 results exceeded revenue expectations, though sales declined year-over-year. The company raised its full-year revenue guidance. Despite a 4.4% sales drop to $211.2 million, Neogen's non-GAAP profit per share significantly beat analyst estimates. Full-year revenue guidance was slightly increased. The company cited strong Food Safety performance contrasted with supplier issues in Animal Safety, while transformation initiatives aim to improve future margins.